<DOC>
	<DOCNO>NCT00838838</DOCNO>
	<brief_summary>Both condition hypogonadism immobilisation ( paraplegia ) may contribute lead decrease bone mineral density resp osteoporosis . In study bone mineral density assess hypogonadal paraplegic patient , standard prophylactic therapy osteoporosis standard physiotherapy exercise program one group receive Nebido testosterone replacement ( TRT ) . The additional effect TRT bone mineral density / osteoporosis assess ( CT scan lumbar spine ) .</brief_summary>
	<brief_title>Efficacy Nebido Bone Mineral Density ( BMD ) Hypogonadal Paraplegic Patients With Confirmed Osteoporosis</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Paraplegia</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Male patient &gt; 18yrs Osteoporosis prophylaxis/therapy vitamin D 800 1200 mg per day , calcium 800 1000 mg per day , Fosamax 70 week . Standardised physiotherapy exercise programme . No proliferative bone disease . No history calcium oxalate stone . No use aromatase inhibitor . No use 5alpha reductase inhibitor . Nebido group : No contraindication use Nebido ( know prostate breast carcinoma suspicion thereof , past present history liver tumour ) ; No know hypersensitivity testosterone excipients Nebido Androgen dependent carcinoma prostate male mammary gland , past present history liver tumour , hypersensitivity towards active pharmaceutical ingredient ingredient .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Testosterone replacement therapy</keyword>
	<keyword>Hypogonadism</keyword>
	<keyword>Osteoporosis</keyword>
	<keyword>Immobilisation</keyword>
	<keyword>Paraplegia</keyword>
	<keyword>Testosterone</keyword>
</DOC>